This page is no longer used please use www.akleg.gov
28th Legislature(2013-2014)

Bill Text 28th Legislature


00 Enrolled SB 162                                                                                                         
01 Authorizing a licensed optometrist to prescribe a pharmaceutical agent containing                                       
02 hydrocodone.                                                                                                            
03                           _______________                                                                               
04    * Section 1. AS 08.72.272(a) is amended to read:                                                                   
05            (a)  A licensee may prescribe and use a pharmaceutical agent, including a                                    
06       controlled substance, in the practice of optometry if                                                             
07                 (1)  the pharmaceutical agent                                                                           
08                      (A)  is prescribed and used for the treatment of ocular disease or                                 
09            conditions, ocular adnexal disease or conditions, or emergency anaphylaxis;                                  
10                      (B)  is not a schedule IA, IIA, or VIA controlled substance;                                   
11            however, notwithstanding this subparagraph, a licensee may prescribe                                     
12            and use a pharmaceutical agent containing hydrocodone;                                                   
13                      (C)  is prescribed in a quantity that does not exceed four days of                                 
14            prescribed use if it is a controlled substance;                                                              
01                      (D)  is not injected into the ocular globe of the eye; and                                         
02                      (E)  is not a derivative of clostridium botulinum; and                                             
03                 (2)  the licensee                                                                                       
04                      (A)  has a physician-patient relationship, as defined by the                                       
05            board in regulations adopted under this chapter, with the person to whom the                                 
06            pharmaceutical agent is prescribed; and                                                                      
07                      (B)  has on file with the department the licensee's current                                        
08            federal Drug Enforcement Administration registration number that is valid for                                
09            the controlled substance prescribed or used.                                                                 
New Text Underlined     [DELETED TEXT BRACKETED]